Caveolin-1 Variant Is Associated With the Metabolic Syndrome in Kuwaiti Children
- PMID: 30622557
- PMCID: PMC6308323
- DOI: 10.3389/fgene.2018.00689
Caveolin-1 Variant Is Associated With the Metabolic Syndrome in Kuwaiti Children
Erratum in
-
Corrigendum: Caveolin-1 Variant Is Associated With the Metabolic Syndrome in Kuwaiti Children.Front Genet. 2019 Mar 20;10:221. doi: 10.3389/fgene.2019.00221. eCollection 2019. Front Genet. 2019. PMID: 30949197 Free PMC article.
Abstract
Caveolin-1 (CAV1) variants have been suggested to be associated with obesity and related metabolic disorders, but information based on human studies is limited. In the present study, we aimed to investigate the potential association between the CAV1 rs1997623 C/A variant and metabolic syndrome (MetS) in Kuwaiti children. DNA from saliva samples collected from 1313 Kuwaiti children (mean age: 12 years) were genotyped using the TaqMan SNP genotyping assay. The classification of MetS was based on the presence/absence of four indicators; (1) central obesity, (2) elevated systolic or diastolic blood pressure, (3) low salivary high-density lipoprotein cholesterol (HDLC), and (4) high salivary glucose. In this study, children with MetS scored ≥3, children in the intermediate metabolic group scored 1 or 2 and children without MetS scored 0. About one-third of the children were obese. A total of 246 children (18.7%) were classified as having MetS; 834 children (63.5%) were in the intermediate metabolic group, and 233 children (17.7%) had no indication of MetS. Obesity was highly prevalent in the MetS group (91.9%) while 26.8% of children were obese in the intermediate metabolic group. None of the children were obese in the group without MetS. Analysis of the CAV1 rs1997623 variant revealed a significant association of the A-allele (p = 0.01, Odds Ratio (OR) = 1.66) and the heterozygous CA-genotype (p = 0.005, OR = 1.88) with MetS. Consistently, the A-allele (p = 0.002, OR = 1.71) and CA-genotype (p = 0.005, OR = 1.70) also showed significant association with the intermediate metabolic group. Furthermore, the A-allele (p = 0.01, OR = 1.33) and the CA-genotype (p = 0.008, OR = 1.55) were associated with low levels of saliva HDLC. Individuals who were heterozygous or homozygous for the variant (CA/AA) showed significantly lower levels of high HDLC compared to those harboring the CC-genotype (p = 0.023). Our study revealed a novel association of the CAV1 rs1997623 variant with the MetS and with low saliva HDLC levels in young Kuwaiti children and indicated the need for further in-depth studies to unravel the role of CAV1 gene in the genetic etiology of MetS.
Keywords: CAV1; HDLC; Kuwaiti children; metabolic syndrome; obesity.
Figures



Similar articles
-
Caveolin Gene, a Possible Risk Factor for Metabolic Syndrome in Humans: A Systematic Review and Meta-Analysis.Int J Prev Med. 2025 Jan 31;16:7. doi: 10.4103/ijpvm.ijpvm_216_24. eCollection 2025. Int J Prev Med. 2025. PMID: 40046695 Free PMC article. Review.
-
Caveolin-1 rs1997623 variant and adult metabolic syndrome-Assessing the association in three ethnic cohorts of Arabs, South Asians and South East Asians.Front Genet. 2022 Oct 21;13:1034892. doi: 10.3389/fgene.2022.1034892. eCollection 2022. Front Genet. 2022. PMID: 36338969 Free PMC article.
-
Caveolin-1 rs1997623 Single Nucleotide Polymorphism Creates a New Binding Site for the Early B-Cell Factor 1 That Instigates Adipose Tissue CAV1 Protein Overexpression.Cells. 2022 Dec 6;11(23):3937. doi: 10.3390/cells11233937. Cells. 2022. PMID: 36497195 Free PMC article.
-
A prevalent caveolin-1 gene variant is associated with the metabolic syndrome in Caucasians and Hispanics.Metabolism. 2015 Dec;64(12):1674-81. doi: 10.1016/j.metabol.2015.09.005. Epub 2015 Sep 12. Metabolism. 2015. PMID: 26475177 Free PMC article.
-
Continuous Metabolic Syndrome Scores for Children Using Salivary Biomarkers.PLoS One. 2015 Sep 29;10(9):e0138979. doi: 10.1371/journal.pone.0138979. eCollection 2015. PLoS One. 2015. PMID: 26418011 Free PMC article.
Cited by
-
The interactions between dietary fats intake and Caveolin 1 rs 3807992 polymorphism with fat distribution in overweight and obese women: a cross-sectional study.BMC Med Genomics. 2021 Nov 9;14(1):265. doi: 10.1186/s12920-021-01114-7. BMC Med Genomics. 2021. PMID: 34753501 Free PMC article.
-
Interplay between caveolin-1 and mineralocorticoid receptor in cardiometabolic disease.J Endocrinol. 2024 Jul 18;262(3):e230341. doi: 10.1530/JOE-23-0341. Print 2024 Sep 1. J Endocrinol. 2024. PMID: 38916410 Free PMC article. Review.
-
Caveolin: A New Link Between Diabetes and AD.Cell Mol Neurobiol. 2020 Oct;40(7):1059-1066. doi: 10.1007/s10571-020-00796-4. Epub 2020 Jan 23. Cell Mol Neurobiol. 2020. PMID: 31974905 Free PMC article. Review.
-
Role of Caveolin-1 in Diabetes and Its Complications.Oxid Med Cell Longev. 2020 Jan 27;2020:9761539. doi: 10.1155/2020/9761539. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32082483 Free PMC article. Review.
-
Caveolin Gene, a Possible Risk Factor for Metabolic Syndrome in Humans: A Systematic Review and Meta-Analysis.Int J Prev Med. 2025 Jan 31;16:7. doi: 10.4103/ijpvm.ijpvm_216_24. eCollection 2025. Int J Prev Med. 2025. PMID: 40046695 Free PMC article. Review.
References
-
- Bitar M. S., Abdel-Halim S. M., Al-Mulla F. (2013). Caveolin-1/PTRF upregulation constitutes a mechanism for mediating p53-induced cellular senescence: implications for evidence-based therapy of delayed wound healing in diabetes. Am. J. Physiol. Endocrinol. Metab. 305 E951–E963. 10.1152/ajpendo.00189.2013 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources